147 related articles for article (PubMed ID: 25359714)
1. Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5-Lipo-Oxygenase.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S; Diaz G; Holman TR
Chem Biol Drug Des; 2015 Jul; 86(1):114-21. PubMed ID: 25359714
[TBL] [Abstract][Full Text] [Related]
2. Docking, steered molecular dynamics, and QSAR studies as strategies for studying isoflavonoids as 5-, 12-, and 15-lipoxygenase inhibitors.
Cabezas F; Mascayano C
J Biomol Struct Dyn; 2019 Apr; 37(6):1511-1519. PubMed ID: 29624122
[TBL] [Abstract][Full Text] [Related]
3. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
4. New isoflavonoids as inhibitors of porcine 5-lipoxygenase.
Voss C; Sepulveda-Boza S; Zilliken FW
Biochem Pharmacol; 1992 Jul; 44(1):157-62. PubMed ID: 1632829
[TBL] [Abstract][Full Text] [Related]
5. Identification of 1, 4-Dihydrothieno [3', 2':5, 6]thiopyrano[4, 3-c] pyrazole derivatives as human 5-Lipo-oxygenase inhibitors.
Hu J; Zhu W; Meng H; Liu Y; Wang X; Hu C
Chem Biol Drug Des; 2014 Dec; 84(6):642-7. PubMed ID: 24889744
[TBL] [Abstract][Full Text] [Related]
6. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
8. Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.
Hofmann B; Rödl CB; Kahnt AS; Maier TJ; Michel AA; Hoffmann M; Rau O; Awwad K; Pellowska M; Wurglics M; Wacker M; Zivković A; Fleming I; Schubert-Zsilavecz M; Stark H; Schneider G; Steinhilber D
Br J Pharmacol; 2012 Apr; 165(7):2304-13. PubMed ID: 21955369
[TBL] [Abstract][Full Text] [Related]
9. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Muthuraman S; Sinha S; Vasavi CS; Waidha KM; Basu B; Munussami P; Balamurali MM; Doble M; Saravana Kumar R
Bioorg Med Chem; 2019 Feb; 27(4):604-619. PubMed ID: 30638966
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
[TBL] [Abstract][Full Text] [Related]
12. Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2.
Tsai WC; Gilbert NC; Ohler A; Armstrong M; Perry S; Kalyanaraman C; Yasgar A; Rai G; Simeonov A; Jadhav A; Standley M; Lee HW; Crews P; Iavarone AT; Jacobson MP; Neau DB; Offenbacher AR; Newcomer M; Holman TR
Bioorg Med Chem; 2021 Sep; 46():116349. PubMed ID: 34500187
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the inhibitory activity of ferrocenyl Schiff bases derivatives on 5-lipoxygenase: Computational and biological studies.
Navarrete E; Morales P; Muñoz-Osses M; Vásquez-Martínez Y; Godoy F; Maldonado T; Martí AA; Flores E; Mascayano C
J Inorg Biochem; 2023 Aug; 245():112233. PubMed ID: 37141763
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
Vasquez-Martinez Y; Ohri RV; Kenyon V; Holman TR; Sepúlveda-Boza S
Bioorg Med Chem; 2007 Dec; 15(23):7408-25. PubMed ID: 17869117
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors.
Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P
Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741
[TBL] [Abstract][Full Text] [Related]
16. Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase.
Tsai WC; Aleem AM; Tena J; Rivera-Velazquez M; Brah HS; Tripathi S; D'silva M; Nadler JL; Kalyanaraman C; Jacobson MP; Holman T
Bioorg Med Chem; 2021 Sep; 46():116347. PubMed ID: 34507163
[TBL] [Abstract][Full Text] [Related]
17. A potent and selective inhibitor targeting human and murine 12/15-LOX.
Armstrong MM; Freedman CJ; Jung JE; Zheng Y; Kalyanaraman C; Jacobson MP; Simeonov A; Maloney DJ; van Leyen K; Jadhav A; Holman TR
Bioorg Med Chem; 2016 Mar; 24(6):1183-90. PubMed ID: 26899595
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
Lamie PF; Philoppes JN; Rárová L
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
[TBL] [Abstract][Full Text] [Related]
19. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM
Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor.
Takeda S; Usami N; Yamamoto I; Watanabe K
Drug Metab Dispos; 2009 Aug; 37(8):1733-7. PubMed ID: 19406952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
